Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

G Minotti, P Menna, E Salvatorelli, G Cairo… - Pharmacological …, 2004 - ASPET
The clinical use of anthracyclines like doxorubicin and daunorubicin can be viewed as a sort
of double-edged sword. On the one hand, anthracyclines play an undisputed key role in the …

The HER-2 receptor and breast cancer: ten years of targeted anti–HER-2 therapy and personalized medicine

JS Ross, EA Slodkowska, WF Symmans… - The …, 2009 - academic.oup.com
Learning Objectives Contrast the current strengths and limitations of the three main slide-
based techniques (IHC, FISH, and CISH) currently in clinical use for testing breast cancer …

Neuregulins: functions, forms, and signaling strategies

DL Falls - The EGF Receptor Family, 2003 - Elsevier
Publisher Summary This chapter focuses on neuregulins (NRGs) that are the signaling
proteins that mediate cell–cell interactions in the nervous system, heart, breast, and other …

The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy

JS Ross, JA Fletcher, GP Linette, J Stec, E Clark… - The …, 2003 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Define
the historical background and biological basis of the discovery of the HER-2/neu gene and …

Angiogenic endothelial cell signaling in cardiac hypertrophy and heart failure

R Gogiraju, ML Bochenek, K Schäfer - Frontiers in cardiovascular …, 2019 - frontiersin.org
Endothelial cells are, by number, one of the most abundant cell types in the heart and active
players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in …

Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications

C Osborne, P Wilson, D Tripathy - The oncologist, 2004 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Differentiate between the actions of oncogenes and tumor suppressor genes in the …

Targeted therapy in breast cancer: the HER-2/neu gene and protein

JS Ross, JA Fletcher, KJ Bloom, GP Linette… - Molecular & Cellular …, 2004 - ASBMB
The HER-2/neu oncogene, a member of the epidermal growth factor receptor or erb gene
family, encodes a transmembrane tyrosine kinase receptor that has been linked to prognosis …

Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer

GL Plosker, SJ Keam - Drugs, 2006 - Springer
Trastuzumab (Herceptin®) is a humanised monoclonal antibody used in the treatment of
breast cancer that overexpresses human epidermal growth factor receptor 2 (HER2), which …

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure–2008 update: best practices for the transition of care of heart failure patients …

JMO Arnold, JG Howlett, A Ducharme… - Canadian journal of …, 2008 - Elsevier
Heart failure is a clinical syndrome that normally requires health care to be provided by both
specialists and nonspecialists. This is advantageous because patients benefit from …

Singleshot mesoporous silica rods scaffold for induction of humoral responses against small antigens

MO Dellacherie, A Li, BY Lu… - Advanced Functional …, 2020 - Wiley Online Library
Vaccines have shown significant promise in eliciting protective and therapeutic responses.
However, most effective vaccines require several booster shots, and it is challenging to …